India’s report on patented drug pricing : on unsure ground

Last week saw the release of a draft of the Report of the Committee on Price Negotiation for Patented Drugs. Yet, far from inspiring confidence in India's ability to get a good deal for its patients, it strikes a note of  pessimism that belies the leverage that a strong generics industry and a vast and …

Advertisement

India & drug pricing : Can key word in policy influence impact?

Could a single word in the new drug pricing policy mitigate the extent of its impact on the pharma industry's profitability or is this mere wishful thinking?  A senior industry source claimed to Apothecurry that the choice of "value" instead of "volume" as a determinant of market share (on the basis of which prices will …